Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-11 5:58 pm Unchanged | 2024-11-12 | 13D | Tempest Therapeutics, Inc. TPST | Versant Venture Capital VI, L.P. | 2,118,644 4.800% | 0 (Unchanged) | Filing History |
| 2024-08-12 8:59 pm Unchanged | 2024-08-08 | 13D | Tempest Therapeutics, Inc. TPST | Versant Venture Capital VI, L.P. | 2,118,644 8.400% | 0 (Unchanged) | Filing History |
| 2024-05-13 4:54 pm Unchanged | 2024-03-19 | 13D | Tempest Therapeutics, Inc. TPST | Versant Venture Capital VI, L.P. | 2,118,644 9.500% | 0 (Unchanged) | Filing History |
| 2024-02-14 6:49 pm Sale | 2023-12-31 | 13G | Tempest Therapeutics, Inc. TPST | EcoR1 Capital LLC | 0 0.000% | -1,052,810 (Position Closed) | Filing History |
| 2024-02-14 2:12 pm Sale | 2023-12-31 | 13G | Tempest Therapeutics, Inc. TPST | Rock Springs Capital Management LP | 0 0.000% | -823,654 (Position Closed) | Filing History |
| 2024-02-09 10:05 am Sale | 2024-02-08 | 13G | Tempest Therapeutics, Inc. TPST | FMR LLC | 431,932 2.244% | -215,966 (-33.33%) | Filing History |
| 2024-02-08 5:41 pm Unchanged | 2023-11-08 | 13D | Tempest Therapeutics, Inc. TPST | Versant Venture Capital VI, L.P. | 2,118,644 11.000% | 0 (Unchanged) | Filing History |
| 2023-11-09 5:28 pm Unchanged | 2023-08-10 | 13D | Tempest Therapeutics, Inc. TPST | Versant Venture Capital VI, L.P. | 2,118,644 15.900% | 0 (Unchanged) | Filing History |
| 2023-02-14 2:57 pm Unchanged | 2022-12-31 | 13G | Tempest Therapeutics, Inc. TPST | Rock Springs Capital Management LP | 823,654 7.830% | 0 (Unchanged) | Filing History |
| 2023-02-14 12:10 pm Purchase | 2022-04-29 | 13G | Tempest Therapeutics, Inc. TPST | EcoR1 Capital LLC | 1,052,810 9.990% | 1,052,810 (New Position) | Filing History |
| 2022-05-09 5:26 pm Purchase | 2022-04-29 | 13D | Tempest Therapeutics, Inc. TPST | Versant Venture Capital VI, L.P. | 2,118,644 20.500% | 940,173 (+79.78%) | Filing History |
| 2022-02-17 4:19 pm Purchase | 2021-12-31 | 13G | Tempest Therapeutics, Inc. TPST | LAV Regulus Ltd | 153,744 2.200% | 153,744 (New Position) | Filing History |
| 2022-02-14 4:31 pm Sale | 2021-12-31 | 13G | Millendo Therapeutics, Inc. MLND | Ikarian Capital LLC | 58,803 0.900% | -31,065 (-34.57%) | Filing History |
| 2022-02-14 06:20 am Purchase | 2021-12-31 | 13G | Tempest Therapeutics, Inc. TPST | Roche Finance Ltd | 72,612 1.100% | 72,612 (New Position) | Filing History |
| 2022-02-14 06:12 am Purchase | 2021-12-31 | 13G | Tempest Therapeutics, Inc. TPST | Citadel Advisors LLC | 365 0.000% | 365 (New Position) | Filing History |
| 2022-02-10 7:41 pm Purchase | 2021-12-31 | 13G | Tempest Therapeutics, Inc. TPST | Versant Venture Capital VI, L.P. | 1,178,471 17.100% | 1,178,471 (New Position) | Filing History |
| 2022-01-03 4:15 pm Purchase | 2021-12-22 | 13G | Tempest Therapeutics, Inc. TPST | Rock Springs Capital Management LP | 823,654 11.480% | 513,493 (+165.56%) | Filing History |
| 2021-07-15 4:31 pm Sale | 2021-06-28 | 13G | Tempest Therapeutics, Inc. TPST | Rock Springs Capital Management LP | 310,161 4.670% | -331,994 (-51.70%) | Filing History |
| 2021-07-08 4:25 pm Purchase | 2021-06-28 | 13G | Tempest Therapeutics, Inc. TPST | Rock Springs Capital Management LP | 642,155 9.680% | 642,155 (New Position) | Filing History |
| 2021-07-06 10:59 am Purchase | 2021-07-02 | 13G | Tempest Therapeutics, Inc. TPST | FMR LLC | 647,898 9.764% | 647,898 (New Position) | Filing History |